Language
English
Publication Date
7-1-2025
Journal
The Journal of Nutrition
DOI
10.1016/j.tjnut.2025.05.016
PMID
40414302
PMCID
PMC12673020
PubMedCentral® Posted Date
5-23-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Background: The first month of pregnancy is a key time in early developmental programming. Prenatal vitamin/mineral supplement use during the first month of pregnancy (PNVmo1) was associated with reduced risk of autism spectrum disorder (ASD) in the Markers of Autism Risk in Babies, Learning Early Signs (MARBLES) cohort.
Objectives: We aimed to evaluate the associations between PNVmo1, the placental and umbilical cord serum metabolomes, and the child's later neurodevelopmental outcome in the MARBLES pregnancy cohort.
Methods: Placental (n = 78) and umbilical cord serum (n = 132) metabolomes were investigated using 1H nuclear magnetic resonance spectroscopy. PNVmo1 was determined by self-report. At 36 mo of age, child neurodevelopmental outcomes were classified by MARBLES clinicians into 3 groups: typically developing (TD), ASD, or nontypically developing (Non-TD) but not ASD, which was dominated by developmental delays and/or elevated autism symptoms but not meeting ASD criteria.
Results: After adjustment for covariates, permutational multivariate analysis of variance revealed that PNVmo1 was significantly (P < 0.05) associated with the placental and umbilical cord serum metabolomes. In the placenta, higher concentrations of amino acids were observed in the PNVmo1 group (false discovery rate < 0.1). After adjustment for PNVmo1 and other covariates, permutational multivariate analysis of variance revealed a significant association (P < 0.05) between the placental metabolome and Non-TD outcome status. No associations were observed in the analyses of umbilical cord serum metabolism or with ASD outcome. We tested for but did not find evidence that the placental metabolome explained the relationship between PNVmo1 and Non-TD outcome in an exploratory mediation analysis.
Conclusions: These findings suggest that the placental metabolome could be sensitive to nutrient supplementation during the earliest stages of pregnancy.
Keywords
Humans, Female, Pregnancy, Placenta, Dietary Supplements, Vitamins, Fetal Blood, Cohort Studies, Autism Spectrum Disorder, Adult, Male, Child, Preschool, Metabolome, Infant, prenatal supplementation, metabolomics, placenta, umbilical cord serum, neurodevelopment
Published Open-Access
yes
Recommended Citation
Parenti, Mariana; Schmidt, Rebecca J; Tancredi, Daniel J; et al., "Placental Metabolism Is Linked to Prenatal Vitamin Supplement Use in the First Month of Pregnancy in the MARBLES Cohort" (2025). Faculty, Staff and Students Publications. 8299.
https://digitalcommons.library.tmc.edu/baylor_docs/8299